Although pridopidine has suffered four negative trials for HD, the message from Prilenia continues to be positive. What is hope and what is hype in this sixteen-year quest for regulatory approval?
HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD
Data from the HART study of Huntexil for HD symptoms now published, but we still need a new, larger trial
Huntexil makes headlines with science journal article, but nothing's changed: another trial is needed before approval
European Medicines Agency (EMA) tells NeuroSearch a European license for Huntexil in HD requires another large trial
How can we improve recruitment into Huntington's disease clinical trials? Talking directly with families works!
Bad news for Huntexil – the FDA requires another trial before it can be approved in the US
Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex